Neurava

Wearables To Track Epilepsy

3.5M people in the US and 65M people worldwide have epilepsy. ~35% of the US population do not respond to anti seizure medications. For as long as their seizures remain uncontrolled, epilepsy patients are at risk of a number of complications, including Sudden Unexpected Death from Epilepsy or SUDEP.

SUDEP risk monitoring

Our wearables record key biological signals related to epilepsy and SUDEP

Nighttime Monitoring

Our holistic monitoring approach provides important peace of mind to caregivers in the form of accurate and timely alerts at night

Expedite Treatment

All recorded data is wirelessly transmitted to physicians to expedite formulation of treatment and management plans

“ UCB is proud to support Neurava, a medical device startup leveraging groundbreaking epilepsy research to develop new wearable solutions for patients with epilepsy. Neurava is translating the discovery of a potential mechanism of action behind Sudden Unexpected Death in Epilepsy (SUDEP) into a first-of-its-kind smart wearable device capable of identifying and alerting for seizures and impending SUDEP risk. Because studies suggest that roughly one out of every 1,000 deaths are a result of SUDEP every year in the U.S., a device like this has the potential to save lives in the future. "

-Colin Lake, Head of Digital Business Transformation, U.S. Neurology at UCB

Giving Back Control To Patients With Uncontrolled Epilepsy

Wearables To Track Epilepsy

SUDEP risk monitoring

Nighttime Monitoring

Expedite Treatment

In The News

Our Partners